Judge Selects 40 Abilify Lawsuits For Second Group of Potential Bellwether Trials Over Gambling Risks

The U.S. District Judge presiding over all federal Abilify lawsuits has selected a group of 40 cases that will be included in as part of a second bellwether process, which will be prepared for trial if the parties fail to reach a settlement to resolve claims that the popular antipsychotic caused users to suffer catastrophic damages due to uncontrollable gambling and other compulsive behaviors. 

There are currently about 1,600 lawsuits pending against Bristol-Myers Squibb and Otsuka Pharmaceuticals in the federal court system, each raising similar allegations that the drug makers failed to adequately warn consumers and the medical community about link between Abilify and gambling problems, which have resulted in sudden urges to gamble that users did not recognize as a potential side effect of the drug.

Plaintiffs maintain that they would have avoided devastating Abilify gambling losses if doctors and consumers had been informed about the importance of monitoring for signs of gambling urges.

Did You Know?

Millions of Philips CPAP Machines Recalled

Philips DreamStation, CPAP and BiPAP machines sold in recent years may pose a risk of cancer, lung damage and other injuries.

Learn More

Given similar questions of fact and law, the litigation has been centralized in the Northern District of Florida before U.S. District Judge M. Casey Rodgers, who is presiding over discovery into common issues in the cases and other pretrial proceedings.

A series of three early trial dates were expected to begin this summer, which were designed to help the parties gauge how juries may respond to certain evidence and testimony that may be repeated throughout the litigation. However, the parties reached agreements to settle those Abilify cases in late April 2018.

On August 8, Judge Rodgers issued an order (PDF) establishing a second group of 40 bellwether trial pool cases. Each side has 14 days from the date of the order to strike five of the cases selected, and the remaining pool will be reduced to 30 cases that will be prepared for early trial dates.

Once the strikes have been made, plaintiffs will have until October 12 to turn in a completed fact sheet for each plaintiff, as well as produce all medical, financial and gambling record authorizations. By December 14, each side will strike another five cases, reducing the pool again to 20 cases, which will go through a “reasonable scope” of fact discovery.

Following the completion of discovery, the parties will each select five cases for a final trial pool of 10 claims, and the Court indicates that it will select random replacements for any cases subsequently removed from the pool.

Judge Rodgers indicates that the Court is still considering whether it should consolidate some of the Abilify cases for trial, and that it is leaning toward conducting a consolidated trial.

While the outcomes of these bellwether trials will not be binding on other plaintiffs, they will be closely watched by lawyers involved in the litigation, helping to weigh the relative strengths and weaknesses of their positions. Ultimately, if the parties fail to reach an agreement Abilify settlements for the gambling cases, each individual claim pending in the MDL may be remanded back to U.S. District Courts nationwide for individual trial dates in the future.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Gardasil Lawsuits Over Failure To Warn Doctors About HPV Vaccine Risks Cleared To Move Forward
Gardasil Lawsuits Over Failure To Warn Doctors About HPV Vaccine Risks Cleared To Move Forward (Posted yesterday)

A federal judge has cleared Gardasil lawsuits to move forward, after paring down plaintiffs' claims to those alleging Merck either failed to warn, or fraudulently concealed, the HPV vaccine's risks from the medical community.